Key facts
- Christopher M. Jewell has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $255,114.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Christopher M. Jewell
- Location
- Gaithersburg, MD
- Summary
- The estimated net worth of Christopher M. Jewell is at least $255,114 dollars as of 13 Jan 2025. Christopher M. Jewell is the Chief Scientific Officer of Cartesian Therapeutics, Inc. and owns shares of Cartesian Therapeutics, Inc. (RNAC) stock worth about $255.1K.
- Signature
- /s/ Matthew Bartholomae, Attorney-in-Fact for Christopher Jewell
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Christopher M. Jewell and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Change
- Largest disclosed position: Cartesian Therapeutics, Inc. ($255,114).
- Past-year value change for that position: .
Research use
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Christopher M. Jewell
RNAC
Forms 3/4/5
Cartesian Therapeutics, Inc.
- Relationship
- Chief Scientific Officer
- Holdings value
- $255,114
- Past year net change
- Change %
- Report period
- 10 Jan 2025
Insider Transactions Reported by Christopher M. Jewell:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.